Price T Rowe Associates Inc Tenaya Therapeutics, Inc. Put Options Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TNYA
# of Institutions
90Shares Held
47.2MCall Options Held
35.8KPut Options Held
1.1K-
Column Group LLC San Francisco, CA9.4MShares$28 Million30.64% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$20.1 Million2.84% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$8.53 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY2.85MShares$8.5 Million2.33% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $123M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...